Physician profile
Barry S Gleimer
NPI 1306891627
$2,291.13
in general payments reported to CMS, 2019-2025
27 companies · $379 in 2025
The $379 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $610 · 2020: $54.33 · 2022: $120 · 2023: $473 · 2024: $654 · 2025: $379.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,506.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,506.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $417.35 | 2019-2025 | Accolade, Restoration, Insignia |
| Si-Bone, INC. | $244.10 | 2023-2025 | |
| Depuy Synthes Sales INC. | $228.08 | 2019-2024 | Na, Monovisc, Orthovisc |
| Zimmer Biomet Holdings, INC. | $208.60 | 2019-2024 | Tapestry |
| Nevro Corp. | $169.60 | 2019-2024 | Senza |
| Eclipse Technology Solutions INC. | $159.40 | 2024-2025 | |
| Osteocentric Technologies, INC. | $100.00 | 2023 | Osteocentric 4.0 X 130mm Locking Bone Screw Fastener St |
| Providence Medical Technology, INC. | $75.00 | 2023 | |
| Ferring Pharmaceuticals INC. | $71.39 | 2019 | |
| Davol INC. | $69.77 | 2022-2024 | Arista Ah Flexitip |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $66.20 | 2020-2024 | Relistor |
| Fidia Pharma USA INC. | $59.74 | 2019 | |
| Globus Medical, INC. | $48.54 | 2025 | Senza, Vyrsa V1 |
| Collegium Pharmaceutical, INC. | $46.64 | 2023-2024 | Xtampza, Belbuca |
| Integrity Implants INC. Dba Accelus | $41.09 | 2023 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dynasplint Systems INC. | $40.12 | 2023 | Dynasplint |
| Abbott Laboratories | $38.29 | 2019-2022 | |
| Kci USA, INC. | $33.47 | 2019-2023 | Prevena |
| Bioventus LLC | $26.81 | 2023 | Bonescalpel |
| Medtronic USA, INC. | $26.52 | 2019 | |
| Zyla Life Sciences, INC. | $22.43 | 2019 | |
| Radius Health, INC. | $22.22 | 2025 | Tymlos |
| Baxter Healthcare | $18.36 | 2019 | |
| Next Science LLC | $16.62 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $14.91 | 2025 | |
| Avanos Medical | $14.54 | 2022 | |
| Trice Medical, INC. | $11.34 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Barry Gleimer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.